Overview
- Includes supplementary material: sn.pub/extras
Part of the book series: Methods in Pharmacology and Toxicology (MIPT)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (20 protocols)
-
Introduction
-
Novel Molecular Targets for Cardiac Drug Development
-
Functional Endpoints Evaluating Cardiac Drug Activity
-
Clinical Aspects in Cardiac Drug Development
About this book
Reviews
"The scope of material covered is comprehensive, providing eclectic coverage of some very topical issues in cardiac biology and cardiac medicine...most of the chapters will be of interest to a much wider audience than pharmacologists...a worthwhile purchase." - Journal of Pharmacological and Toxicological Methods
"This textbook is a comprehensive look into the latest in cardiovascular drug developments and novel therapeutic agents. It covers a broad spectrum of therapeutic areas including ionic channels, adenoviral vector delivery for cardiovascular gene therapy, pharmacometrics, and gender differences in heart failure and angiogenesis therapy in coronary heart disease. It would be useful for clinical researchers and pharmacologists in cardiac drug development. Research scientists, graduate students and pharmacologists involved in both the pharmaceutical and biotechnological drug industries would benefit from this book." - E-STREAMS
Editors and Affiliations
Bibliographic Information
Book Title: Cardiac Drug Development Guide
Editors: Michael K. Pugsley
Series Title: Methods in Pharmacology and Toxicology
DOI: https://doi.org/10.1385/1592594042
Publisher: Humana Totowa, NJ
eBook Packages: Springer Protocols
Copyright Information: Springer Science+Business Media New York 2003
Hardcover ISBN: 978-1-58829-097-7Published: 30 July 2003
Softcover ISBN: 978-1-4899-3828-2Published: 14 August 2013
eBook ISBN: 978-1-59259-404-7Published: 06 February 2008
Series ISSN: 1557-2153
Series E-ISSN: 1940-6053
Edition Number: 1
Number of Pages: X, 431
Topics: Pharmacy
Industry Sectors: Biotechnology, Consumer Packaged Goods, Pharma